Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
CG Oncology, Inc. (CGON) had Return on Equity of -6.37% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.67M |
|
$-43.81M |
|
$1.58M |
|
$0.09M |
|
$52.80M |
|
$-51.13M |
|
$7.32M |
|
$-43.81M |
|
$-43.81M |
|
$-43.81M |
|
$-43.81M |
|
$-43.81M |
|
$-43.81M |
|
$-51.13M |
|
$-50.51M |
|
76.73M |
|
76.73M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$695.79M |
|
$15.33M |
|
$34.12M |
|
$729.91M |
|
$30.53M |
|
$3.00M |
|
$11.74M |
|
$42.27M |
|
$687.64M |
|
$673.17M |
|
$687.64M |
|
78.28M |
|
| Cash Flow Statement Financials | |
$-96.13M |
|
$-170.32M |
|
$54.52M |
|
$257.07M |
|
$45.15M |
|
$-211.92M |
|
$19.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.79 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
5.34% |
|
-3068.97% |
|
-3068.97% |
|
-- |
|
-2629.53% |
|
-2629.53% |
|
$-96.26M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
1.05 |
|
3.23 |
|
27.82 |
|
|
Return on Equity |
-6.37% |
-6.51% |
|
-6.00% |
|
-6.34% |
|
$8.78 |
|
$-1.25 |
|
$-1.25 |
|